← Open Payments lookup

BOLAJI BOLARINWA: Open Payments

NPI 1104476381 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$819 in 49 payments from 10 companies in 2025. Trend: 2023 $702 · 2024 $1,036 · 2025 $819

Food & beverage: $819
CompanyPaymentsAmount
ABBVIE INC.13$166
Neurocrine BioSciences, Inc.6$125
Vanda Pharmaceuticals Inc.5$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$91
Alkermes, Inc.5$87
Teva Pharmaceuticals USA, Inc.5$76
Janssen Pharmaceuticals, Inc3$60
Lundbeck LLC3$56
Supernus Pharmaceuticals, Inc.3$48
Otsuka America Pharmaceutical, Inc.1$17

Products named: VRAYLAR, INGREZZA, FANAPT, CAPLYTA, ARISTADA, REXULTI, Qelbree, UZEDY.

Industry payments across NJ — which companies pay providers there.